Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Ciaramella: mRNA Encoded Abs for HIV Prophylaxis |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2016-05-26 |
| Study Made Public: | 2020-06-05 |
Title
Neutralizing activity of mRNA derived bnAbs
Description
CAVD 568 is a monoclonal antibody study evaluating HIV bnAbs expressed from various constructs.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.